X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
mutation (3) 3
dna repair (2) 2
oncology (2) 2
pancreatic cancer (2) 2
tumors (2) 2
animals (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - pharmacology (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
antitumor activity (1) 1
brca mutations (1) 1
brca1 protein (1) 1
brca2 protein (1) 1
breast cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - genetics (1) 1
breast-cancer (1) 1
carboplatin (1) 1
carboplatin - pharmacology (1) 1
cell line, tumor (1) 1
cell survival - drug effects (1) 1
cho cells (1) 1
combination (1) 1
cricetinae (1) 1
cricetulus (1) 1
cytotoxicity (1) 1
dna damage (1) 1
dna methylation (1) 1
dna-damage (1) 1
drug therapy (1) 1
enzyme inhibitors - pharmacology (1) 1
female (1) 1
gene silencing (1) 1
genes, brca1 (1) 1
genes, brca2 (1) 1
genetic aspects (1) 1
health aspects (1) 1
histone h2ax (1) 1
homologous recombination (1) 1
homologous recombination repair (1) 1
humans (1) 1
hypermethylation (1) 1
in-vivo (1) 1
index medicus (1) 1
indoles - pharmacology (1) 1
inhibitor drugs (1) 1
mammary-tumors (1) 1
mice (1) 1
mice, nude (1) 1
mutations (1) 1
neoplasms - drug therapy (1) 1
neoplasms - genetics (1) 1
ovarian cancer (1) 1
ovarian neoplasms - drug therapy (1) 1
ovarian neoplasms - genetics (1) 1
pancreatic neoplasms - drug therapy (1) 1
pancreatic neoplasms - genetics (1) 1
poly polymerase (1) 1
poly polymerase inhibitors (1) 1
poly polymerases - metabolism (1) 1
repair (1) 1
research (1) 1
risk factors (1) 1
sporadic breast (1) 1
transplantation, heterologous (1) 1
usage (1) 1
xenografts (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2011, Volume 103, Issue 4, pp. 334 - 346
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2011, Volume 103, Issue 4, pp. 334 - 346
BACKGROUND: Mutations in BRCA1 and BRCA2 (BRCA1/2), components of the homologous recombination DNA repair (HRR) pathway, are associated with hereditary breast... 
BRCA2 protein | BRCA1 protein | DNA damage | Poly(ADP-ribose) polymerase | Cytotoxicity | Breast cancer | DNA repair | Ovarian cancer | Homologous recombination repair | homologous recombination | Pancreatic cancer | Xenografts | Carboplatin | Antitumor activity | Mutation | Tumors
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 02/2011, Volume 103, Issue 4, p. 334
Mutations in BRCAI and BRCA2 (BRCA1/2), components of the homologous recombination DNA repair (HRR) pathway, are associated with hereditary breast and ovarian... 
Inhibitor drugs | Oncology | Mutation | DNA repair | Tumors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.